Psychedelic Stocks,Shroom News Atai Life Sciences Launches PsyProtix to Develop Psychiatric Therapy for TRD By Dennis Mutua October 13, 2021 Clinical stage biopharmaceutical company seeking to transform the treatment of mental health disorders Atai Life Sciences NV (NASDAQ: ATAI) announced having launched PsyProtix a precision unit specializing on developing therapeuti...
Featured,Trends & Articles Arcata City Council Votes Unanimously to Decriminalize Psychedelics By Dennis Mutua October 13, 2021 In the beginning of the week, the Arcata City Council voted unanimously for a proposal seeking to effectively decriminalize use and possession of psilocybin mushrooms and other entheogenic plants like peyote and ayahuasca. Enth...
Featured,Trends & Articles Numinus Integrates Psychedelic Lab to Level Up Research Capacity By Dennis Mutua October 12, 2021 Mental healthcare company focusing on advancing innovative treatments and safe, psychedelic-assisted therapies for mental illnesses Numinus Wellness Inc. (CVE: NUMI) has integrated its psychedelic research facility so as to increa...
Psychedelic Stocks,Shroom News Psyched Wellness Commences Pre-Clinical Trial Study of Amanita Muscaria (AME-1) By Dennis Mutua October 11, 2021 Health supplement company focusing on protecting, restoring and regaining a healthier body and mind through production and distribution of medical mushrooms Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYFC) announced having commenc...
Psychedelic Stocks,Shroom News Tryp Therapeutics Enters Into a Partnership With Researchers From University of Wisconsin-Madison By Dennis Mutua October 08, 2021 Pharmaceutical company focusing on identifying and developing psychedelic drugs beyond mental health Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announced having entered into a partnership with researchers from University of...
Featured,Trends & Articles Novamind Unveils a Psychedelic Palliative Care Program By Dennis Mutua October 08, 2021 Mental healthcare company making investments in infrastructure for specialized practitioners to administer psychedelic therapies Novamind Inc. (CSE: NM) (OTCQB: NVMDF) has launched a psychedelic palliative program at its newly ope...
Psychedelic Stocks,Trends & Articles Delic Labs Applies for Dealer’s License to Test Compounds Outside Psychedelic Mushroom By Dennis Mutua October 07, 2021 Leading research laboratory specializing on extraction, chemical process development, advanced cannabis testing and vape-smoke analysis for the psychedelic wellness industry Delic Holding Corp Inc. (CSE: DELC) (OTCQB: DELCF) annou...
Featured,Shroom News PharmaTher Commences Phase 2 Clinical Trial for Treatment of Parkinson’s Disease By Dennis Mutua October 07, 2021 Clinical stage biotechnology company focusing on research, development and commercialization of psychedelic pharmaceuticals PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) says that it has started phase 2 KET-LID clinical tria...